Immediate Impact

1 from Science/Nature 34 standout
Sub-graph 1 of 16

Citing Papers

Vascular endothelial growth factor signaling in health and disease: from molecular mechanisms to therapeutic perspectives
2025 Standout
Insights into IL-6/JAK/STAT3 signaling in the tumor microenvironment: Implications for cancer therapy
2025 Standout
2 intermediate papers

Works of Donna Vickery being referenced

Belzutifan plus cabozantinib for patients with advanced clear cell renal cell carcinoma previously treated with immunotherapy: an open-label, single-arm, phase 2 study
2023
LBA88 Belzutifan versus everolimus in participants (pts) with previously treated advanced clear cell renal cell carcinoma (ccRCC): Randomized open-label phase III LITESPARK-005 study
2023

Author Peers

Author Last Decade Papers Cites
Donna Vickery 125 94 93 96 15 265
Caio César Barbosa Bomfim 52 108 31 74 15 298
Benedikt Kolbrink 51 130 37 46 19 263
JoAnn Lim 65 53 13 131 21 316
Pei Wan 49 102 74 81 16 301
Friedrich Alexander von Samson‐Himmelstjerna 48 100 34 42 16 213
Bo Liu 91 114 45 27 15 268
Leigh Ragone 91 87 52 55 19 237
Carla L. Bregman 44 79 14 64 13 295
Limin Wang 49 87 59 113 18 272
Mehdi Baratchian 38 84 35 45 11 307

All Works

Loading papers...

Rankless by CCL
2026